Danfeng Ren Selected Research

Mitogen-Activated Protein Kinase 14

12/2023

Treatment with β-Adrenoceptor Agonist Isoproterenol Reduces Non-parenchymal Cell Responses in LPS/D-GalN-Induced Liver Injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Danfeng Ren Research Topics

Disease

3	Hepatitis B 10/2019 - 01/2019
2	Inflammation (Inflammations) 12/2023 - 01/2023
2	Infections 10/2019 - 01/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 12/2023
1	Venous Thromboembolism 01/2023
1	Septic Shock (Toxic Shock Syndrome) 01/2023
1	Sepsis (Septicemia) 01/2023
1	Hemorrhage 01/2023
1	Hepatitis 01/2021
1	Visceral Leishmaniasis (Kala Azar) 01/2021
1	Pathologic Constriction (Stenosis) 10/2016

Drug/Important Bio-Agent (IBA)

2	Tenofovir (Viread)FDA Link 10/2019 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2019
1	Mitogen-Activated Protein Kinase 14IBA 12/2023
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 12/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023
1	Dacarbazine (DIC)FDA LinkGeneric 01/2023
1	AnticoagulantsIBA 01/2023
1	InterferonsIBA 01/2021
1	liposomal amphotericin B FDA Link 01/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2019
1	Telbivudine FDA Link 10/2019
1	hepatitis B hyperimmune globulinIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2019
1	Ischemic Postconditioning 10/2016